Australia National Pathology Standards (First Edition 2027) 4.02: GX laboratory pathologist and clinical scientist supervision: at least one full-time equivalent pathologist with the relevant scope who is onsite in a laboratory 80 percent of the time and readily available with delegated supervision for each test, a risk assessment of complex tests to decide whether adding a clinical scientist would improve quality, at least one clinical scientist with delegated responsibility for the analytical phase of each tissue typing, complex toxicology and complex genomics test, and a process to set the clinical scientist's full-time equivalency

What does 4.02 require?

A GX laboratory keeps, in aggregate, at least one full-time-equivalent pathologist with the relevant scope who is physically in a laboratory four days in five and is on call for each test with delegated supervisory responsibility. It assesses the risk of its complex tests, at minimum against volume, acuity, errors, feedback, complaints and poor outcomes, to decide whether a clinical scientist should join the supervision arrangement. Tissue typing, specialist toxicology (confirmation of drugs of abuse, interpretively complex therapeutic drug monitoring, mass spectrometry methods, as opposed to routine assays such as paracetamol or ethanol) and large-scale genomics (karyotyping, genome, exome and large panel sequencing, and other testing needing expert integrative judgement) each have a clinical scientist with the relevant scope responsible for the analytical phase, and the practice has a way of working out how much of that scientist's time is needed. The national blood service is treated as a GX laboratory.